Members |
targetComponentId |
Legal abort med sæbeemboli |
Induced termination of pregnancy complicated by soap embolism |
Legal abortion with specified complication, NEC |
Induced termination of pregnancy (procedure) |
legal abort med uræmi |
Induced termination of pregnancy complicated by uraemia |
Legal abort med urinvejsinfektion |
Induced termination of pregnancy complicated by urinary tract infection |
legal abort uden komplikationer |
Induced termination of pregnancy (procedure) |
juridisk vejledning |
Medicolegal advice |
legal blindhed, USA |
Blindness AND/OR vision impairment level |
legal blindhed |
Blindness AND/OR vision impairment level |
Legal service NOS |
Law occupation (occupation) |
Legal service NOS |
Law occupation (occupation) |
Patients retsstilling |
Legal status |
legalt provokeret svangerskabsafbrydelse |
Induced termination of pregnancy (procedure) |
Legalt provokeret abort, ikke nærmere specificeret |
Induced termination of pregnancy (procedure) |
Legionella antibody test NOS |
Measurement of Legionella species antibody (procedure) |
Legionella antibody test NOS |
Measurement of Legionella species antibody (procedure) |
Legionella bozemanae |
Legionella bozemanae (organism) |
Legionella dumoffii |
Legionella dumoffii |
Legionella gormanii |
Legionella gormanii |
Legionella micdadei |
Legionella micdadei |
Leigh syndrome with nephrotic syndrome |
Leigh's disease |
leiomyom |
Leiomyoma |
leiomyomatose |
Leiomyomatosis |
leiomyomatøst neoplasme iht. kategori |
Leiomyomatous neoplasm |
leiomyosarkom iht. kategori |
Leiomyosarcoma |
Leiomyosarkom |
Leiomyosarcoma |
Leishmaniacides |
Antiprotozoal |
Lemon - dietary |
Lemon (substance) |
Varighed af fødsel, ikke nærmere specificeret |
Duration of labor |
Length of labour NOS |
Duration of labor |
lenograstim 263 µg pulver og solvens til injektionsvæske, opløsning, hætteglas |
Product containing only lenograstim in parenteral dose form (medicinal product form) |
Lenograstim 263micrograms powder for conventional release solution for injection vial |
Product containing only lenograstim in parenteral dose form (medicinal product form) |
Lepromatous cutaneous leishmaniasis |
Diffuse cutaneous leishmaniasis |
Leptospira inadei |
Leptospira inadai |
Leptospira interrogans |
Leptospira interrogans |
Leptospirosis due to other specific organisms |
Leptospirosis |
Leptospirosis icterohemorrhagica |
Weil's disease |
Weils sygdom |
Weil's disease |
Leptospirosis risk exposure (& [Weil's disease]) |
At increased risk of exposure to Leptospira |
Leptospirosis risk exposure (& [Weil's disease]) |
At increased risk of exposure to Leptospira |
Eksponering for leptospiroserisiko |
At increased risk of exposure to Leptospira |
Lepus victoriae |
Lepus microtis subspecies microtus (organism) |
Lesion endoscopic destruction NOS |
Endoscopic destruction of lesion (procedure) |
Lesion endoscopic destruction NOS |
Endoscopic destruction of lesion (procedure) |
Letal neonatal spasticitet |
A rare genetic neurological disorder characterized by neonatal onset of rigidity and intractable seizures, with episodic jerking already beginning in utero. Affected infants have small heads, remain visually inattentive, do not feed independently, and make no developmental progress. Frequent spontaneous apnea and bradycardia usually culminate in cardiopulmonary arrest and death in infancy, although some cases were described with a milder clinical course and survival into childhood. |
Letterer-Siwes sygdom med ekstranodal lokalisation OG/ELLER lokalisation i massivt organ |
Langerhans cell histiocytosis, disseminated (disorder) |
Letterer-Siwes sygdom i intraabdominale lymfeknuder |
Disseminated Langerhans cell histiocytosis of abdominal lymph nodes (disorder) |
Letterer-Siwes sygdom i intrapelvine lymfeknuder |
Disseminated Langerhans cell histiocytosis of pelvic lymph nodes (disorder) |
Letterer-Siwes sygdom i intratorakale lymfeknuder |
Disseminated Langerhans cell histiocytosis of lymph nodes of thorax (disorder) |
Letterer-Siwes sygdom i lymfeknuder i aksil OG/ELLER overekstremitet |
Disseminated Langerhans cell histiocytosis of lymph nodes of upper limb (disorder) |
Letterer-Siwe disease of lymph nodes of axilla and upper limb |
Disseminated Langerhans cell histiocytosis of lymph nodes of upper limb (disorder) |
Letterer-Siwe disease of lymph nodes of head |
Disseminated Langerhans cell histiocytosis of lymph nodes of head (disorder) |
Letterer-Siwes sygdom i lymfeknuder i ingvinalregion OG/ELLER underekstremitet |
Disseminated Langerhans cell histiocytosis of lymph nodes of lower limb (disorder) |
Letterer-Siwe disease of lymph nodes of inguinal region and lower limb |
Disseminated Langerhans cell histiocytosis of lymph nodes of lower limb (disorder) |
Letterer-Siwe disease of lymph nodes of lower limb |
Disseminated Langerhans cell histiocytosis of lymph nodes of lower limb (disorder) |
Letterer-Siwes sygdom i lymfeknuder, multiple lokalisationer |
Disseminated Langerhans cell histiocytosis of lymph nodes of multiple sites (disorder) |
Letterer-Siwe disease of lymph nodes of neck |
Disseminated Langerhans cell histiocytosis of cervical lymph nodes (disorder) |
Letterer-Siwe disease of lymph nodes of upper limb |
Disseminated Langerhans cell histiocytosis of lymph nodes of upper limb (disorder) |
Letterer-Siwes sygdom i milten |
Disseminated Langerhans cell histiocytosis of spleen (disorder) |
Letterer-Siwe's disease |
Langerhans cell histiocytosis, disseminated |
Lettuce - dietary |
Lettuce (substance) |
Leucaena glauca |
Leucaena leucocephala |
Leukodystrofi uden kendt biokemisk grundlag |
Leucodystrophy |
Leuconostoc fructosum |
Fructobacillus fructosus (organism) |
Leuconostoc garviae |
Lactococcus garvieae (organism) |
Leuconostoc oenos |
Oenococcus oeni |
Leuconostoc paramesenteroides |
Weissella paramesenteroides |
Leucotomy NEC |
Leukotomy |
Leukaemia - specif. cell NOS |
Leukaemia |
Leukaemia of unspecified cell type |
Leukaemia |
leukæmi iht. kategori |
Leukaemia |
Leukæmi spec. celle, ikke nærmere specificeret |
Leukaemia |
Leukæmi, uspecificeret celletype |
Leukaemia |
Leukæmi |
Leukaemia |
Leukemic reticuloendotheliosis |
Hairy cell leukemia |
Hårcelleleukæmi, ekstranodal OG/ELLER organlokaliseret |
Hairy cell leukemia |
Leuprolide acetate 11.25mg |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
Leuprolide acetate 11.25mg injection |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
leuprorelinacetat 11,25 mg pulver til injektionsvæske, suspension, hætteglas |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
Leuprorelin only product in parenteral dose form |
Leuprolide acetate 15mg powder for injection suspension vial |
Leuprorelin only product in parenteral dose form |
Leuprolide acetate 22.5mg |
Leuprorelin only product in parenteral dose form |
leuprorelinacetat 22,5 mg pulver til injektionsvæske, suspension, hætteglas |
Leuprorelin only product in parenteral dose form |
Leuprolide acetate 30mg |
Leuprorelin acetate 20 mg/mL suspension for injection |
leuprorelinacetat 30 mg pulver til injektionsvæske, suspension, hætteglas |
Leuprorelin acetate 20 mg/mL suspension for injection |
leuprorelinacetat 45 mg pulver til injektionsvæske, suspension, hætteglas |
Product containing precisely leuprorelin acetate 120 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
Leuprolide acetate 7.5mg |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
Leuprolide acetate 7.5mg injection |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
leuprorelinacetat 7,5 mg pulver til injektionsvæske, suspension, hætteglas |
Leuprorelin acetate 7.5 mg/mL suspension for injection |
Levafix-sort |
Textile colours and finishes patch test substance |
levafix-brilliantblå |
Textile colours and finishes patch test substance |
levafix-brilliantgul |
Textile colours and finishes patch test substance |
Levafix-farvestof |
Textile colours and finishes patch test substance |
levafix-marineblå |
Textile colours and finishes patch test substance |
levalbuterol 45 µg med HFA-aerosolinhalator med afmålt dosis |
Product containing only levosalbutamol (medicinal product) |
levobetaxololhydrochlorid 0,5 % suspension til oftalmisk anvendelse |
Levobetaxolol 5 mg/mL eye suspension |
Levobunolol hydrochloride 0.5% conventional release eye drops |
Levobunolol hydrochloride 5 mg/mL eye solution |
levobunololhydrochlorid 0,5% øjendråber til engangsbrug |
Levobunolol hydrochloride 5 mg/mL eye solution |
levobupivacain 1,25 mg/ml injektionsvæske, opløsning, pose a 200 ml |
Product containing precisely levobupivacaine (as levobupivacaine hydrochloride) 1.25 milligram/1 milliliter conventional release solution for injection (clinical drug) |
Levocetirizine 2.5mg/5mL oral solution |
Levocetirizine dihydrochloride 500 microgram/mL oral solution |
levofloxacin 1,5 % opløsning til oftalmisk anvendelse |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) |
levofloxacin 25 mg/ml oral opløsning |
Product containing precisely levofloxacin anhydrous (as levofloxacin) 25 milligram/1 milliliter conventional release oral solution (clinical drug) |